(Q37283670)

19 August 2017

1 reference

title

Prevention and treatment of pregnancy-associated hypertension: what have we learned in the last 10 years? (English)

1 reference

19 August 2017

0 references

1 reference

1

Remuzzi G

1 reference

19 August 2017

2

Ruggenenti P

1 reference

19 August 2017

1 September 1991

1 reference

American Journal of Kidney Diseases

19 August 2017

1 reference

19 August 2017

18

1 reference

19 August 2017

3

1 reference

19 August 2017

285-305

1 reference

Studies on blood pressure during pregnancy. I. Influence of parity and age

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Pregnancy in women with kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Late postpartum eclampsia: an update.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Preeclampsia: pathophysiology, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Early onset pre-eclampsia: recognition of underlying renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Pregnancy-induced hypertension complicated by acute liver disease and disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Pregnancy and systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Phaeochromocytoma presenting in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Pregnancy and Primary Aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Plasma antithrombin III activity: an aid in the diagnosis of preeclampsia-eclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Antithrombin III levels in normotensive and hypertensive pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Blood levels of proteinase inhibitors in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Increased sensitivity to thromboplastin synthesis in blood monocytes from pre-eclamptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Hypocalciuria in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Increased levels of carboxyhemoglobin and serum iron as an indicator of increased red cell turnover in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Clinical applications of the altered iron kinetics of toxemia of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Antibodies to laminin in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Mitogenic activity is increased in the sera of preeclamptic women before delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and preeclampsia in urban black women

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Short-term neonatal morbidity associated with prematurity and the effect of a prematurity prevention program on expected incidence of morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Preeclampsia: a hyperdynamic disease model

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Hemodynamic measurements in preeclampsia: preliminary observations.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Effects of normal pregnancy on cellular cation metabolism and peripheral vascular resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Pressor response to angiotonin in pregnant and nonpregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

A study of angiotensin II pressor response throughout primigravid pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Renal hemodynamics and tubular function normal human pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Serial changes in 24 hour creatinine clearance during normal menstrual cycles and the first trimester of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Adrenergic innervation of uterine vasculature in human term pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Observations on the loss of catecholamine fluorescence from intrauterine adrenergic nerves during pregnancy in the guinea-pig

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Prostacyclin produced by the pregnant uterus in the dog may act as a circulating vasodepressor substance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

A double blind placebo controlled crossover study of prostacyclin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Synthesis and structure of the platelet aggregation factor thromboxane A2

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Alterations in platelet concentration and aggregation in normal pregnancy and preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Effect of low-dose aspirin on angiotensin II pressor response in human pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Mechanisms regulating renin release

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Prostaglandins and renin release: I. Stimulation of renin release from rabbit renal cortical slices by PGI2

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Antimineralocorticoid Action of Progesterone in the Rat: Correlation of the Effect on Electrolyte Excretion and Interaction with Renal Mineralocorticoid Receptors*

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Longitudinal evaluation of hemodynamic changes in eclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Cardiovascular alterations in severe pregnancy-induced hypertension: acute effects of intravenous magnesium sulfate.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Hemodynamic observations in severe pre-eclampsia with a flow-directed pulmonary artery catheter.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

The central hemodynamics of severe preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Erythrocyte cation metabolism in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Platelets and the beginnings of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Insulin resistance in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

The effect of insulin on renal sodium metabolism. A review with clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Chronic Intravascular Coagulation in Normal Pregnancy and Preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Thromboxane A2 synthesis in pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Contractile action of a stable prostaglandin endoperoxide analogue on the human umbilical artery

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Effects of vasoactive autacoids on the human umbilical-fetal placental vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Preeclampsia: an imbalance in placental prostacyclin and thromboxane production

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Decrease prostacyclin production: a characteristic of chronic placental insufficiency syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Prostacyclin activity in amniotic fluid in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Platelet count in normal, small, and anemic fetuses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Doppler umbilical and uterine flow waveforms in severe pregnancy hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Doppler ultrasound of the uteroplacental circulation as a screening test for severe pre-eclampsia with intra-uterine growth retardation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Uterine artery Doppler velocimetry in pregnant women with hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Doppler uteroplacental waveforms in pregnancy-induced hypertension: a re-appraisal.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Effect of Low-Dose Aspirin on Fetal and Maternal Generation of Thromboxane by Platelets in Women at Risk for Ppregnancy-Induced Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Overview of randomised trials of diuretics in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

LABETALOL AND PLATELET FUNCTION IN PRE-ECLAMPSIA

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Calcium metabolism in normal pregnancy: A longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

The relationship between calcium intake and pregnancy-induced hypertension: up-to-date evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Preliminary evidence of the effect of calcium supplementation on blood pressure in normal pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Effect of calcium supplementation on the vascular sensitivity to angiotensin II in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Effect of calcium supplementation on the vascular sensitivity to angiotensin II in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Prevention of pre-eclampsia by early antiplatelet therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Low-dose aspirin in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Prophylactic low-dose aspirin and dipyridamole in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Low-dose aspirin improves fetal weight in umbilical placental insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Plasma volume expansion in the treatment of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Studies of colloid osmotic pressure in pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Responsiveness to norepinephrine of the vessels supplying the placenta of growth-retarded fetuses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Treatment of severe pregnancy-associated hypertension with the calcium antagonist nifedipine.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Nifedipine and Platelets in Preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

The effect of a calcium channel blocker (nifedipine) on uterine blood flow in the pregnant goat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Nifedipine: effects on fetal and maternal hemodynamics in pregnant sheep.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

The use of a calcium antagonist (nifedipine) to suppress preterm labour

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Tocolytic and hemodynamic effects of nifedipine in the ewe

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Nifedipine as a second line antihypertensive drug in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Magnesium: Nature's physiologic calcium blocker

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Magnesium plus nifedipine: potentiation of hypotensive effect in preeclampsia?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Acute effect of an antihypertensive drug, labetalol, on uteroplacental blood flow.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Labetalol does not alter the placental and fetal blood flow or maternal prostanoids in pre-eclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

The Effect of Blockade of the Beta Receptors of the Sympathetic Nervous System of the Fetus: A Preliminary Report

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Maternal Beta-Adreneceptor Blockade Reduces Fetal Tolerance to Asphyxia: A study in pregnant sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Enalapril for pregnancy-induced hypertension: acute renal failure in a neonate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Neonatal renal failure: a complication of maternal antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Infusion of diazoxide in severe hypertension during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Minibolus diazoxide in the management of severe hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Sodium nitroprusside for control of severe hypertensive disease of pregnancy: a case report and discussion of potential toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Diazepam in Labour: Its Metabolism and Effect on the Clinical Condition and Thermogenesis of the Newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Placental transfer of diazepam and its disposition in the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Phenytoin infusion in severe pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Magnesium sulfate: rationale for its use in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Evidence that prostacyclin mediates the vascular action of magnesium in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Cardiopulmonary arrest due to acute maternal hypermagnesaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Phenytoin sodium and magnesium sulphate in the management of eclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Pregnancy toxemia and sodium chloride. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

THE INFLUENCE OF DIETARY SALT INTAKE ON PRE-ECLAMPSIA

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Sodium depletion simulating deterioration in a toxemic pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Fetal outcome in trial of antihypertensive treatment in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Neonatal head circumference and the treatment of maternal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Hypertension during pregnancy with and without specific treatment; the development of the children at the age of four years.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Treatment of hypertension in pregnancy with methyldopa: blood pressure control and side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Influence of maternal alpha-methyldopa on sympathetic innervation in the newborn rabbit heart

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Is clonidine a behavioural teratogen in the human?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

First year of life after the use of atenolol in pregnancy associated hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Atenolol in essential hypertension during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Clinical pharmacological studies with prazosin during pregnancy complicated by hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Pheochromocytoma: antepartum diagnosis and management with tumor resection in the puerperium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Extraadrenal pheochromocytoma: detection during pregnancy using MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Clinical Pharmacology of Labetalol in Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Treatment of normotensive and hypertensive patients with preterm labor using oral nifedipine, a calcium antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Obstetric importance, diagnosis, and management of fetal tachycardias

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

FATAL HEMORRHAGIC PANCREATITIS FOLLOWING CHLOROTHIAZIDE ADMINISTRATION IN PREGNANCY

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

NEONATAL THROMBOCYTOPENIA ASSOCIATED WITH ANTE-PARTUM ADMINISTRATION OF THIAZIDE DRUGS.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980087-4

7 January 2021

10.1016/S0272-6386(12)80087-4

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

1882820